Skip to content

Clinical trials

Heart Arrest trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Arrest Country / region: China Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20123
20143
20151
20161
20172
20194
20214
20222
20235
20244
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13
Recruiting9
Completed6
Active, not recruiting5
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tang Ziren5
Capital Medical University4
Peking University Third Hospital3
Beijing Anzhen Hospital2
Peking Union Medical College Hospital2
Qilu Hospital of Shandong University2
Shanghai 10th People's Hospital2
Beijing Tiantan Hospital1
Biohaven Pharmaceuticals, Inc.1
Central China Fuwai Hospital of Zhengzhou University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Arrest36
Brain Injuries4
Heart Failure4
Shock, Cardiogenic4
Death, Sudden, Cardiac2
Post-Cardiac Arrest Syndrome2
Respiratory Distress Syndrome2
Acute Kidney Injury1
Angina, Unstable1
Aortic Diseases1

Trials

Showing 76 to 36 of 36. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.